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Introduction 
Liver disease is a serious public health issue in the UK[1]. Scotland in particular has cirrhosis 
mortality rates double that of the European average. [2]. Liver disease predisposes the patient to 
numerous complications and they are at an increased risk of critical illness[3]. Admissions with 
cirrhosis doubled in the UK between 2003 and 2008. This is likely to increase further [4, 5]. 
Admissions with cirrhosis have a high mortality with Thomson et al reporting a mortality rate of 45%. 
[5]. With each additional failing organ system, ICU mortality rates increase. [6]. Renal failure and 
sepsis with cirrhosis are associated with particularly poor outcomes[7]. This poor prognosis has led 
to questions regarding the admission of some of these patients to ICU[4]. 
It is becoming increasingly important to be able to identify who might benefit from admission to the 
ICU. A number of different scoring tools have been used for this purpose[8]. Most studies are from 
Asia or from transplant centres [9]. These centres have a different case mix of cirrhotic patients 
compared to the general ICU [4, 10, 11]. More data is needed from the non-transplant setting to 
establish whether evidence from the these specialist centres is transferrable to the general ICU, 
where a high proportion of critically ill cirrhosis patients are treated[12] 
The aim of the present study was to examine the characteristics of a cohort of critically ill patients 
with cirrhosis who were admitted to a general ICU over a 12 month period. We aimed to analyse the 
utility of prognostic scoring tools in these patients and to identify whether liver specific or general 
ICU scoring tools have a greater discriminative ability. In addition, we identified any independent 
predictors of mortality. 
Materials and Methods 
This study was approved by the Local Research Ethics Committee; (West of Scotland Research Ethics 
Committee 5, approved 20th March 2012, REC reference; 12/WS/0039.) Data was collected 
prospectively over a period of 12 months (June 2012 to May 2013) from the Glasgow Royal Infirmary 
(GRI) ICU. The ICU has 20 critical care beds and is a mixed surgical / medical unit, affiliated with the 
University of Glasgow. The ICU does not offer a dedicated hepatology critical care service and the 
hospital does not offer tertiary liver transplant services.  
Patients 
All ICU admissions at the GRI between June 2012 and June 2013 had their records screened for a 
diagnosis of cirrhosis. ICU patients were defined as those referred to and accepted for level 3 care. 
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This involves requiring advanced respiratory support or basic respiratory support together with the 
support of at least two organ systems[13].  
Cirrhosis was diagnosed either histologically or via clinical suspicion. Clinically, a patient was deemed 
cirrhotic if they had features of chronic liver disease with evidence of portal hypertension, ascites, 
encephalopathy or a liver-spleen scan consistent with cirrhosis. An independent clinician verified the 
diagnosis of cirrhosis. Only patients over the age of 18 were included in the study.  
Methods 
Clinical and demographic data were collected prospectively via the patient record (CareVue, Philips 
Medical Systems, Eindhoven, The Netherlands) upon admission to the unit to allow the calculation of 
the different scoring systems. Demographic data collection included: Age, gender, aetiology of 
cirrhosis, primary diagnosis on ICU admission and Scottish Index of Multiple Deprivation (SIMD) 
category. Clinical data collected on admission included: Sodium, potassium, bilirubin, creatinine, 
urine output (at 6, 12 and 24hrs), weight, urea, lactate, white cell count (WCC), platelets, PT ratio, 
albumin, PaO2:FiO2 ratio, mean arterial pressure (MAP), inotrope dose, pre-intubation 
encephalopathy / Glasgow Coma Score (GCS) and ascites grade. Additional variables were collected 
at 72hrs to enable the Sequential Organ Failure Assessment (SOFA) score[14] and Acute Kidney 
Injury Network (AKIN) score[15] to be calculated on day 3 of admission. This electronic database is 
validated and complete[16].  
Encephalopathy grade (and GCS) was assigned pre-intubation according to the West Haven 
Criteria[17] by the admitting clinician. The ascites grade was assigned according to the International 
Ascites Club definition[18].  
Patients were further categorised according to organ failure status. These were categorised into any 
combination of renal, cardiovascular, respiratory, or no failing organs. A patient was deemed to have 
failing kidneys if they required renal replacement therapy (RRT), cardiovascular failure if they 
required inotropic or vasopressor support, and respiratory failure if they needed mechanical 
ventilation. 
Outcome data was obtained via electronic records and no further patient follow up occurred. No 
patients were lost to follow up. 
Scoring systems 
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Eight scoring tools were analysed initially. Liver specific scoring tools included the Child-Turcotte-
Pugh (CTP)[19], the Model for End-stage Liver Disease (MELD)[20], and the UK End-stage Liver 
Disease model (UKELD)[21]. The CTP score has been in use for a number of years, whereas MELD 
and UKELD are more recent scores and are predominantly used in the transplant setting. The 
Glasgow Alcoholic Hepatitis Score (GAHS)[22] was included based on recent evidence from Thomson 
et al suggesting it might be of use in a critical care setting[5]. The Acute Physiology and Chronic 
Health Evaluation II (APACHE II)[23] score and the Sequential Organ Failure Assessment (SOFA)[14] 
scores are routinely used, and they were the general ICU scores that we analysed. The Acute Kidney 
Injury Network score (AKIN) is a renal specific score in routine use to assess kidney injury[15] 
The Chronic Liver Failure – Sequential Organ Failure Assessment (CLIF-SOFA) score[24] is an adaption 
of the SOFA score, and has been recently developed as part of a large multi-centred study 
investigating acute on chronic liver failure[24].  
SOFA and AKIN scores were calculated at 72 hours to allow us to investigate whether their 
prognostic accuracy differs after patients have been subject to three days of intensive care 
treatment. 
Statistical analysis 
Normally distributed data are reported as mean ± standard deviation. Student’s t-test was used to 
compare parametric data. Non-normally distributed continuous variables are reported as median 
(interquartile range) and were compared using the Mann-Whitney U-test. Proportions were 
compared using a chi-square test or Fisher exact test if required. Significance testing was two sided 
and deemed significant if p < 0.05.  
Multivariate, backward, stepwise logistic regression analysis was performed on selected significant 
variables to identify any independent factors associated with mortality. 
All scoring tools were compared using receiver operator characteristic (ROC) curves. The area under 
the curve (AUC) provided the discriminative ability of the score. Optimum cut-off points were 
selected by the investigators based on the most clinically applicable sensitivity and specificity values.  
All analysis was performed using SPSS. (SPSS Inc, IBM, Chicago, Illinois, USA v.18.) Statistical advice 
was provided by an independent statistician.  
Results 
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62 patients were admitted to the ICU over the 12 month period. Upon independent verification of 
cirrhosis, three patients were excluded as definitive evidence of cirrhosis could not be confirmed. 
This left a cohort of 59 critically ill cirrhosis patients. Patient characteristics are shown in Table 1. The 
mean age was 51 ± 12 years, 40 (68%) were male, and alcohol was the main cause of cirrhosis (80%). 
The most common primary diagnoses on admission were respiratory failure (39%), and gastro-
intestinal bleeding (16%). ICU and hospital mortality were 31% and 48% respectively. 
Risk factors for mortality: Univariate analysis 
Table 1 also shows the results of the univariate analysis of variables associated with ICU mortality. 
There was no significant difference in age (p = 0.451), cause of cirrhosis (p = 0.466), reason for 
admission (p =0.437) or deprivation status (p = 0.275). Patients who died during their stay in the ICU 
had significantly higher prognostic scores in all scores other than in AKIN (CTP, MELD, UKELD, GAHS, 
APACHE II, SOFA and CLIF-SOFA). 
Of the clinical variables, bilirubin and PT ratio were significantly associated with ICU mortality (p = 
0.007 and 0.02 respectively). Lactate and the presence of ascites were also significantly associated 
with mortality (p < 0.001 and p=0.021 respectively). Interestingly acute kidney injury (AKI) and 
encephalopathy were not significantly associated with ICU mortality (p = 0.598 and 0.151 
respectively).  
Multivariate analysis 
A multivariate, backward stepwise logistic regression analysis was undertaken to identify any 
independent factors in determining ICU outcome. Prognostic scores were not included in this 
analysis as this study aimed to establish individual risk factors. The results are given in Table 2 
showing that lactate and ascites on admission are independent predictors of ICU mortality. These 
gave odds ratios of 1.69 and 5.91 respectively. Both are statistically significant with p = 0.008 and 
0.018. 
Lactate 
This study adds to the accumulating body of evidence that serum arterial lactate is an independent 
predictor of mortality[25–28]. We therefore analysed the incorporation of lactate into scoring 
models. The CTP score was chosen as the model in which lactate would be incorporated because of 
its relative simplicity and ease of calculation. It can be calculated at the bedside without the need of 
a calculator or a computer programme, unlike MELD, UKELD, APACHE II and SOFA / CLIF – SOFA. 
Burroughs et al[26] have also recommended the incorporation of lactate into the CTP score. 
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Our two alterations to the CTP score, provisionally termed CTP – L and CTP + L can be found in Table 
3. The CTP – L involves the insertion of a new category: Lactate. As with the previous five categories 
we assigned a score ranging from 1 to 3. An admission lactate of < 2 mmol/l gave a score of one, of 
2.0 – 4.0 mmol/l gave a score of 2, and > 4.1 mmol/l gave a score of three. These three lactate cut-
off values were chosen based on commonly reported cut-off values in intensive care settings[29]. 
The minimum available CTP-L score is therefore 6, with the maximum being 24. 
The second alteration was termed the Child-Turcotte-Pugh + Lactate score (CTP + L). In this, we took 
the overall CTP score for a patient (with no defined units) and simply added the admission serum 
lactate (mmol/l) onto this score. We removed any units assigned to the numbers, and this produced 
the new score. The CTP + L is therefore continuous, with the minimum score possible being 5, and 
the maximum being limited by the physiological range of serum lactate. 
ROC curve analysis 
ROC curves for all scores analysed are presented in Table 4. Of the established scoring tools, SOFA 
performed the best, with an AUC of 0.76 (0.64 – 0.89), with CLIF-SOFA producing a similar AUC of 
0.75 (0.62 – 0.88). All the scores performed to a similar standard of between 0.70 and 0.76 (other 
than AKIN), although none reached the clinically useful AUC level of 0.8[30]. The AKIN score 
performed poorly with an AUC of 0.52 (0.35 – 0.69).  
37 patients remained in the ICU at 72 hours post admission. Of the 22 who were not in the unit at 72 
hours, 9 had died and 13 had been discharged to other areas. Both the SOFA and AKIN scores at 72 
hours performed very similarly to the score at 0 hours. 
The AUC for the two CTP alterations to incorporate lactate (CTP-L and CTP + L) are also shown in 
Table 4. The incorporation of lactate improved the discriminative ability of the scores, with the 
CTP-L producing an AUC of 0.78 (0.64 – 0.91). The CTP + L improved further and produced the 
highest AUC of any score, with an AUC of 0.86 (0.75 – 0.97). The ROC curves of the CTP, CTP-L and 
the CTP+L are presented in Figure 1.  
 
Discussion 
This one year prospective cohort study has evaluated the outcome of 59 consecutive patients with 
cirrhosis admitted to a large, general ICU in the UK. 18 of these patients died in the unit, giving an 
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ICU mortality of 31% over the period of June 2012 to May 2013. This compares favourably to the 
literature in which a weighted ICU mortality of 45% has been reported[31]. 
The primary outcome of this study was that SOFA was the best performing prognostic tool of the 
established scoring systems in critically ill cirrhosis patients admitted to a general, non-transplant 
ICU. The study also identified that lactate and ascites were independent predictors of ICU 
mortality, and that the incorporation of lactate into the CTP, (via the CT  + L score) improved its 
discriminative ability. This contrasts with the other scores analysed, none of which reached the 
clinically useful threshold AUC of 0.8[30]. 
The 31% mortality rate in this study is lower than reported in a review of the literature by Flood et 
al[31]. This reflects the trend towards improved outcomes of these patients over time[32], and 
compares to the 38% and 39% recently reported from two studies in British non-transplant ICUs[5, 
10]. A likely explanation for the low mortality rates may be the comparative low degree of hepatic 
dysfunction seen in our patients. 47% (28/59) were classified as Child-Pugh category C, and the 
median MELD score was 18. Both of these indicators of hepatic disease severity are the lowest of 
any published paper in this area. As in other studies from non-transplant centres [6] this is likely to 
be a result of local referral patterns and the associated selection bias.  
The prognostic effect of AKI on critically ill patients with liver cirrhosis has been extensively 
investigated [7, 28, 33, 34]. It has been established that it is associated with a poor prognosis, with 
Cholongitas et al[28] quoting 71% to 91% ICU mortality depending on the severity of AKI. This was 
not seen in the present study, where there was no significant relationship between AKI on admission 
and ICU mortality (p = 0.598). This may have been caused by a heavy selection bias resulting from 
local referral patterns within the hospital. Critically ill cirrhosis patients with AKI are only likely to be 
admitted to the ICU if it was believed they had a realistic chance of survival. Patients with a 
reversible precipitating factor are more likely to be referred for level 3 care. Those without a 
reversible precipitating factor tend to be managed at ward level. This relates to an important paper 
by Martin-Llahi et al in which they show that the cause of renal failure is of importance in patients 
with cirrhosis[35]. It is possible that patients in the present study had a more benign and transient 
form of AKI because of their lower degree of hepatic dysfunction and the heavy selection bias. This is 
logical and may explain the comparative low ICU mortality rates, and the low prognostic ability of 
the scoring systems, many of which have a renal function component.   
Of the established scoring tools, the SOFA score had the best discriminative ability, with an AUC of 
0.76, this is consistent with much of the literature[36–39] and is to be expected in our cohort who 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
8 
 
seem to be admitted to the ICU with cirrhosis rather than because of their cirrhosis. The relatively 
low discriminative ability of the scores is consistent with the limited amount of literature from a 
non-transplant setting[5, 10, 26] and this paper supports the evidence suggesting that scoring 
tools should not be used independently in deciding who should be admitted to the ICU in a non-
transplant setting. 
Lactate and ascites were independent predictors of ICU mortality in our patient cohort. Lactate 
produced a statistically significant odds ratio of 1.69, and when incorporated into the CTP score to 
produce the CTP + L score produced an AUC of 0.86. A cut-off point of >14 produces a sensitivity of 
78% and a specificity of 98%, which suggests that it is of more clinical use than the other scores 
analysed. An AUC of 0.86 is the greatest of any score identified from within a non-transplant 
critically ill cirrhosis cohort. As well as being the best discriminative score so far observed, the CTP 
+ L score is not a major revision of the CTP score. It remains simple, quick and easy to calculate at 
the bedside – a factor considered important by the authors. The serum arterial lactate is routinely 
collected in the ICU, and can be collected on the wards. A simple addition of the lactate level in 
mmol/l into the CTP score produces the CTP + L score and provides clinicians with clinically useful 
scoring tool. Although the CTP + L score requires extensive validation in different ICU cirrhosis 
cohorts before it can be used with confidence, this study suggests that clinicians should analyse 
serum arterial lactate levels when triaging critically ill patients with cirrhosis. 
For the first time, the link between deprivation and patients admitted to the ICU with cirrhosis has 
been investigated. Although deprivation was not associated with ICU outcome (p = 0.275), the 
majority of patients (81%) in this study were in the bottom two most deprived quintiles of society.  
This has been suspected for a number of years, but this study has provided some quantification.  
This study provides information on the impact of organ failure on ICU outcome, the utility of scoring 
tools in a general ICU setting, and it has also put forward a potential new way of stratifying these 
patients – the CTP + L score. The prospective nature of the study means that pre-intubation 
encephalopathy and GCS scores could be obtained. This means that certain scores such as SOFA 
and CTP are likely to be more robust than in previous studies, which have listed the inability to 
obtain pre-intubation encephalopathy scores as a significant limitation [5]. 
The 12 month study period allowed us to recruit 59 patients, which is a lower number than previous 
papers[5, 38, 39]. The prospective methodology does however provide us with reliable information 
regarding how many of these patients present to a general, non-transplant ICU over a one year 
period. It provides us with contemporary data that is applicable to a large number of clinicians, and 
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adds to the much needed, limited body of evidence regarding these patients in a non-transplant 
setting. Further work is ongoing to extend the sample size which will allow the authors to 
investigate fully how best to integrate lactate into a scoring tool.  
In conclusion, this year long, prospective study of critically ill cirrhosis patients admitted to a general 
ICU has identified lower than expected ICU mortality. In contrast to the literature, AKI was not as 
negative a prognostic marker as previously reported. The SOFA score was the best performing 
prognostic tool, but none of the scores performed to a clinically useful level. Lactate and ascites 
were independent predictors of ICU mortality, and when lactate was incorporated directly into the 
CTP score to produce the CTP + L score, its discriminative ability increased to a level whereby it 
may be of clinical use. 
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Table and figure legends 
Table 1.  
Clinical characteristics and predictive factors of ICU mortality determined by univariate analysis in 59 
cirrhosis patients admitted to a general ICU. Data are displayed as mean ± standard deviation, 
median (interquartile range). Categorical data is reported as within group number and (%). 
 
Table 2. 
Odds ratios of variables remaining in the multivariate regression model. 
 
Table 3. 
The methodology of calculating the CTP-L and CTP + L scores. 
 
Table 4. 
The area under the curves, cut off points, sensitivity and specificity and optimum cut-off points of 
the prognostic scoring tools analysed.  
 
Figure 1.  
The Receiver Operator Characteristics curves (ROC curves) of the CTP, CTP-L and CTP + L scores.  
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All patients 
 (n=59) 
 
ICU Survivors 
 (n=41) 
ICU Non-survivors 
 (n=18) P value 
          
Age (years) 51 ± 12   50 ± 12 52 ± 12 0.451 
Gender (male) 40 (68%)   27 (66%) 13 (72%) 0.435 
Cause of cirrhosis n(%) 
    
0.466 
        Alcohol 47 (80%) 
 
32 (78%) 15 (83%) 
         Non-alcoholic 12 (20%)   9 (22%) 3 (17%)   
Length of stay (days) 5 (42)    5 (32) 4 (42) 0.167 
Reason for ICU admission 
    
0.437 
        Respiratory failure 23 (39%) 
 
16 (39%) 7 (39%) 
         Gastrointestinal bleed 10 (16%) 
 
6 (15%) 4 (22%) 
         Encephalopathy 5 (9%) 
 
4 (10%) 1 (5%) 
         Sepsis 5 (9%) 
 
2 (5%) 3 (17%) 
         Other 16 (27%)   13 (31%) 3 (17%)   
Number of organs requiring support 
   
0.017 
0 1 (2%) 
 
0 (0%) 1 (5%) 
 1 17 (28%) 
 
16 (39%) 1 (5%) 
 2 30 (51%) 
 
20 (48%) 10 (56%) 
 3 11 (19%)   5 (12%) 6 (34%)   
Prognostic scores on ICU admission  
            APACHE II 22 (16-27) 
 
19 (15-24) 23 (21-33) 0.009 
        Child-Pugh 9 (7-12) 
 
9 (7-11) 11.5 (9-13) 0.013 
        MELD 18 (8-23) 
 
13 (7-21) 21 (19-32) 0.003 
        AKIN 0 (0-2) 
 
0 (0-2) 0 (0-2) 0.791 
        UKELD 51 (48-57) 
 
51 (47-53) 58 (50-62) 0.015 
        GAHS 7 (6-9) 
 
7 (6-8) 8.5 (7-10) 0.004 
        SOFA 10 (8-12) 
 
9 (6-11) 11 (10-14) 0.001 
        CLIF-SOFA 10 (10-12)   9 (9-11) 11.5 (10-14) 0.002 
Clinical parameters  
            AKI 20 (34%) 
 
14 (34%) 6 (33%) 0.598 
       Ascites 26 (44%) 
 
14 (34%) 12 (67%) 0.021 
       Encephalopathy 19 (32%)   11 (27%) 8 (44%) 0.151 
Biological parameters on admission 
            Sodium (mmol/l) 137 ± 6 
 
137 ± 6 136 ± 6 0.534 
        Creatinine (μmol/L) 124 ± 89 
 
112 ± 77 152 ± 108 0.117 
        Bilirubiin (μmol/L) 91 ± 109 
 
67 ± 86 148 ± 134 0.007 
        PT ratio 1.7 ± 0.7 
 
1.6 ± 0.5 2.0 ± 0.9 0.02 
        Lactate (mmol/l) 2.9 ± 3.4 
 
1.8 ± 1.3 5.5 ± 5.1 <0.001 
        Urea (mmol/L) 10.1 ± 7.8 
 
10.1 ±  8.5 10.5 ± 6.2 0.846 
        WBC (10
9
/L) 14.0 ± 8.2 
 
13.7 ± 7.4 14.8 ± 10.0 0.638 
        Platelets (10
9
/L) 130 ± 85 
 
143 ± 89 102 ± 75 0.094 
        Albumin (g/L) 20 ± 6 
 
20 ± 6.3 20 ± 6.5 0.932 
        Potassium (mmol/l) 4.2 ± 0.85 
 
4.1 ±  0.9 4.3 ± 0.8 0.481 
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        PaO2:FiO2 ratio 25.9 ± 19.3    27.4 ± 20.3 23.1 ± 17.7 0.447 
Deprivation  (SIMD category) 
    
0.275 
         1-2 (deprived) 48 (81%) 
 
32 (78%) 18 (89%) 
          3-5 (non-deprived) 11 (19%)   9 (22%) 2 (11%)   
Hospital mortality  28 (48%) 
    ICU mortality  18 (31%)   
   APACHE II, Acute Physiology And Chronic Health Evaluation II score, PT ratio; Prothrombin Time ratio, SOFA; Sequential 
Organ Failure Assessment. 
MELD; Model for End-stage Liver Disease, UKELD; UK Ens-stage Liver Disease model, ICU; Intensive Care Unit, WBC; 
White Blood Count 
 AKIN; Acute Kidney Injury Network score, AKI; Acute Kidney Injury, GAHS; Glasgow Alcoholic Hepatitis score, SIMD; 
Scottish Index of Multiple Deprivation. 
 
Table 1.  Clinical characteristics Predictive factors of ICU mortality determined by univariate analysis 
in 59 cirrhosis patients admitted to a general ICU. 
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Table 2. Odds ratios of variables remaining in the multivariate regression model. 
  
       Variable 
 
Odds Ratio 
 
95% C.I. 
 
P value 
              
Lactate 
 
1.69 
 
1.15 - 2.49 
 
0.008 
Ascites   5.91   1.35 - 25.88   0.018 
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The Child-Turcotte-Pugh - Lactate score (CTP - L) 
   
       Variable   1 point   2 points   3 points 
       
Bilirubin (µmol/l) < 34 
 
34-50 
 
> 50 
Albumin (g/l) > 35 
 
28 -35 
 
< 28 
INR (or PT ratio) < 1.7 
 
1.71 -2.30 
 
>2.3 
Lactate (mmol/l) < 2.0 
 
2.1 -4.0 
 
> 4.1 
Ascites 
 
None 
 
Mild 
 
Severe 
Hepatic Encephalopathy None   Grade I / II   Grade III / IV 
                     
The Child-Turcotte-Pugh + Lactate score (CTP+L) 
   
       Variable   1 point   2 points   3 points 
       Bilirubin (µmol/l) < 34 
 
34-50 
 
> 50 
Albumin (g/l) > 35 
 
28 -35 
 
< 28 
INR (or PT ratio) < 1.7 
 
1.71 -2.30 
 
>2.3 
Ascites 
 
None 
 
Mild 
 
Severe 
Hepatic Encephalopathy None 
 
Grade I / II 
 
Grade III / IV 
Serum arterial lactate Addition to overall score gained from above categories 
 
 
 
     The overall CTP score is calculated according to the five criteria above.  THE CTP + L 
score is calculated via the addition to this score of the serum arterial lactate level 
in mmol/l. Once done, any units associated are removed, to give an overall, continuous 
score.             
 
Table 3. The methodology of calculating the CTP-L and CTP + L scores. 
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Scoring system 
 
AUC 95% C.I. Cut-off point Sens (%) Spec (%) 
        
 
    
Established liver specific scoring systems 
               Child-Turcotte-Pugh (CTP) 
 
0.7 0.55 - 0.85 9.5 61 62 
         Glasgow Alcoholic Hepatitis Score (GAHS) 
 
0.73 0.59 - 0.87 7.5 67 66 
         Model for End-stage Liver Disease (MELD) 
 
0.74 0.61 - 0.88 18 83 67 
         UK Model for End-stage Liver Disease (UKELD)   0.7 0.55 - 0.85 54 61 97 
Established general ICU scoring systems 
               Acute Physiology And Chronic Health Evaluation II (APACHE II) 
 
0.72 0.58 - 0.85 22 61 68 
         Sequential Organ Failure Assessment Score (SOFA)   0.76 0.64 - 0.89 10.5 72 69 
Renal specific scoring tool 
               Acute Kidney Injury Network score (AKIN)   0.52 0.35 - 0.69 2.5 22 93 
Proposed scoring system 
                CLIF - SOFA   0.75 0.62 - 0.88 10.5 83 59 
72 hour scores 
               72 hour SOFA 
 
0.74 0.57 - 0.90 10.5 78 68 
         72 hour AKIN   0.52 0.30 - 0.75 2.5 22 85 
Novel scoring systems proposed in this paper 
               CTP-L  
 
0.78 0.64 - 0.91 11.5 72 68 
         CTP + L   0.86 0.75 - 0.97 14 78 90 
AUC; Area Under the Curve. CTP-L; Child-Turcotte-Pugh with lactate. CTP + L; Child-Turcotte-Pugh + Lactate     
Sens; Sensitivity, Spec; Specificity             
 
Table 4. The area under the curves, cut off points, sensitivity and specificity and optimum cut-off points of the prognostic scoring tools analysed. 
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Figure 1 
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Highlights 
 Mortality for patients admitted to a general ICU,  with a background of liver cirrhosis, maybe 
lower than previously reported in the literature; 
 Lactate and ascites were independent predictors of ICU mortality in this cohort of patients; 
 The simple addition of serum lactate levels into the Child- Turcotte-Pugh score may provide 
a clinically useful scoring tool for critical care clinicians. 
